kinetic study on the reactions of platinum drugs with glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Catalytic Glutathione Oxidation and Platinum(IV)
Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium Flavin Catalyst Organometallics The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs PMC A platinum(IV) prodrug strategy to overcome glutathione based oxaliplatin resistance Communications Chemistry Taming glutathione potentiates metallodrug action ScienceDirect
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



